Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis [3]

Bone Marrow Transplantation

Volumn 35, Issue 4, 2005, Pages 419-420

  Thaunat, O ^a   Alyanakian, M A ^a   Varnous, S ^b   Bors, V ^b   Damaj, G ^a   Rerolle, J P ^a   Jondeau, K ^c   Varet, B ^a   Gandjbakhch, I ^b   Buzyn, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CONGESTIVE HEART FAILURE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEART AMYLOIDOSIS; HEART ARREST; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MULTIPLE MYELOMA; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SYMPTOMATOLOGY; TIME;

AMYLOIDOSIS; BONE MARROW TRANSPLANTATION; FEMALE; HEART TRANSPLANTATION; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 20044362565     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704772     Document Type: Letter

References (8)

1. Dispenzieri A, Kyle RA, Gertz MA et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003; 361: 1787-1789.
2. Dubrey S, Simms RW, Skinner M et al. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival. Am J Cardiol 1995; 76: 739-741.
3. Dubrey SW, Burke MM, Khaghani A et al. Long term results of heart transplantation in patients with amyloid heart disease. Heart 2001; 85: 202-207.
4. Guillaume B, Straetmans N, Jadoul M et al. Allogeneic bone marrow transplantation for AL amyloidosis. Bone Marrow Transplant 1997; 20: 907-908.
5. Gillmore JD, Davies J, Iqbal A et al. Allogeneic bone marrow transplantation for systemic AL amyloidosis. Br J Haematol 1998; 100: 226-228.
6. Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002; 99: 4276-4282.
7. Mohty M, Albat B, Fegueux N, Rossi JF. Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis. Leuk Lymphoma 2001; 41: 221-223.
8. Skinner M, Sanchorawala V, Seldin DC et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004; 140: 85-93.